Entegris Reports Strong Q4 Results with Improved Cash Flow
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Should l Buy ENTG?
Source: Yahoo Finance
- Financial Overview: Entegris reported net sales of $824 million in Q4 2025, with GAAP diluted EPS at $0.32 and non-GAAP diluted EPS at $0.70, reflecting ongoing strength in liquid filtration and CMP consumables, thereby reinforcing its market position.
- Profitability Enhancement: The adjusted gross margin stood at 44.0% and adjusted operating margin at 21.2%, indicating improved profitability despite a slight decline in overall sales, which is expected to positively impact future financial performance through operational optimization and cost control.
- Cash Flow Improvement: The company saw significant improvement in free cash flow for 2025, with expectations for continued enhancement in cash generation in 2026, further strengthening the balance sheet and supporting incremental deleveraging, thus enhancing financial stability.
- Optimistic Market Outlook: Entegris anticipates Q1 2026 sales between $785 million and $825 million, with GAAP net income expected to range from $65 million to $77 million, indicating strong demand for complex device architectures driven by rapid AI technology growth, suggesting substantial future growth potential.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ENTG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ENTG
Wall Street analysts forecast ENTG stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENTG is 98.29 USD with a low forecast of 75.00 USD and a high forecast of 115.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
5 Buy
1 Hold
1 Sell
Moderate Buy
Current: 122.370
Low
75.00
Averages
98.29
High
115.00
Current: 122.370
Low
75.00
Averages
98.29
High
115.00
About ENTG
Entegris, Inc. is a supplier of critical advanced materials and process solutions for semiconductors and other high-technology industries. Its segments include Materials Solutions (MS) and Advanced Purity Solutions (APS). The MS segment provides materials-based solutions, such as chemical vapor and atomic layer deposition materials, chemical mechanical planarization (CMP) slurries and pads, ion implantation specialty gases, formulated etch and clean materials, and other specialty materials. The APS segment offers filtration, purification and contamination-control solutions that improve customers’ yield and device reliability by ensuring the purity of critical liquid chemistries and gases and the cleanliness of wafers and other substrates used throughout semiconductor manufacturing processes, the semiconductor ecosystem and other high-technology industries. It has manufacturing, customer service and/or research facilities in the United States, Canada, China, Germany and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Release Date: Entegris is set to announce its Q4 earnings on February 10 before market open, with a consensus EPS estimate of $0.66, reflecting a 21.4% year-over-year decline, indicating potential competitive pressures.
- Revenue Decline Forecast: The expected revenue for Q4 is $811.28 million, down 4.6% year-over-year, suggesting challenges in sales growth that could impact investor confidence moving forward.
- Historical Performance: Over the past two years, Entegris has beaten EPS estimates 88% of the time and revenue estimates 100% of the time, demonstrating financial forecasting stability despite current downward revisions.
- Estimate Revision Trends: In the last three months, EPS estimates have seen one upward revision and two downward revisions, while revenue estimates have experienced one upward and one downward revision, reflecting market uncertainty regarding the company's future performance.
See More
- Profit Decline: Entegris reported a net profit of $49.4 million for Q4, translating to $0.32 per share, which marks a significant drop from last year's $102.3 million and $0.67 per share, indicating a notable weakening in the company's profitability.
- Revenue Decrease: The company's revenue for the fourth quarter was $823.9 million, a 3% decline from $849.8 million last year, reflecting soft market demand and intensified competition negatively impacting performance.
- Adjusted Earnings: Excluding special items, Entegris reported adjusted earnings of $106.5 million, or $0.70 per share, which, despite a decline from last year, remains higher than the GAAP reported earnings per share, indicating efforts in cost control.
- Future Guidance: The company provided guidance for the next quarter's EPS in the range of $0.70 to $0.78, with expected revenue between $785 million and $825 million, reflecting management's cautiously optimistic outlook for future performance.
See More

Market Opening: U.S. stock markets are set to open in two hours.
Credo Technology Group Performance: Credo Technology Group Holding Ltd. (CRDO) saw an increase of 18.2% in pre-market trading.
Spotify Performance: Spotify Technology S.A. (SPOT) experienced an 11.2% rise in pre-market trading.
Overall Market Sentiment: The significant gains in these stocks indicate positive market sentiment ahead of the market opening.
See More
- Earnings Beat: Entegris reported a Q4 non-GAAP EPS of $0.70, exceeding expectations by $0.04, which reflects strong profitability and boosts investor confidence in the company's financial health.
- Slight Revenue Decline: Revenue of $824 million, down 3.1% year-over-year, still surpassed market expectations by $12.72 million, indicating the company's resilience in maintaining stable sales amid challenges.
- Optimistic Guidance: For Q1 2026, the company expects sales between $785 million and $825 million, slightly below the $787.7 million consensus, demonstrating a cautiously optimistic outlook from management regarding future market conditions.
- Increased Profit Expectations: Projected GAAP net income is between $65 million and $77 million, with non-GAAP EPS expected to range from $0.70 to $0.78, both above market expectations, reflecting ongoing improvements in cost control and profitability.
See More
- Financial Overview: Entegris reported net sales of $824 million in Q4 2025, with GAAP diluted EPS at $0.32 and non-GAAP diluted EPS at $0.70, reflecting ongoing strength in liquid filtration and CMP consumables, thereby reinforcing its market position.
- Profitability Enhancement: The adjusted gross margin stood at 44.0% and adjusted operating margin at 21.2%, indicating improved profitability despite a slight decline in overall sales, which is expected to positively impact future financial performance through operational optimization and cost control.
- Cash Flow Improvement: The company saw significant improvement in free cash flow for 2025, with expectations for continued enhancement in cash generation in 2026, further strengthening the balance sheet and supporting incremental deleveraging, thus enhancing financial stability.
- Optimistic Market Outlook: Entegris anticipates Q1 2026 sales between $785 million and $825 million, with GAAP net income expected to range from $65 million to $77 million, indicating strong demand for complex device architectures driven by rapid AI technology growth, suggesting substantial future growth potential.
See More
- West Pharmaceutical Ex-Dividend: West Pharmaceutical Services, Inc. (WST) will trade ex-dividend on January 28, 2026, with a quarterly dividend of $0.22, leading to an expected price drop of approximately 0.09%, indicating a stable dividend payment history.
- Heritage Financial Dividend Update: Heritage Financial Corp (HFWA) is set to pay a quarterly dividend of $0.24 on February 11, 2026, with an anticipated price drop of about 0.90%, reflecting a relatively high annual yield of 3.61%.
- Entegris Dividend Details: Entegris Inc (ENTG) will pay a quarterly dividend of $0.10 on February 18, 2026, with an expected price decline of around 0.09%, showing a stable annual yield of 0.35%.
- Market Performance Overview: On Monday, shares of West Pharmaceutical, Heritage Financial, and Entegris fell by approximately 4.5%, 5.5%, and 3.2%, respectively, indicating market reactions to the upcoming ex-dividend dates.
See More








